Atopic dermatitis Trials in Berlin, Germany
Conditions / Atopic dermatitis / Berlin, Germany
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
78 total trials for this combination
Showing top 10 of 78 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04392154 | Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) | COMPLETED | PHASE3 |
| NCT01949311 | Open-label Study of Dupilumab in Patients With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03131648 | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) | COMPLETED | PHASE3 |
| NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | TERMINATED | PHASE3 |
| NCT02345928 | A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis | COMPLETED | PHASE1 |
| NCT05882877 | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05398445 | A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) | COMPLETED | PHASE3 |
| NCT00475605 | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis | TERMINATED | — |
| NCT05651711 | A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) | COMPLETED | PHASE3 |
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | COMPLETED | PHASE3 |